Strong Financial Performance
Tenet Healthcare reported net operating revenues of $5.1 billion for Q3 2024. Consolidated adjusted EBITDA was $978 million, showing a 15% increase over Q3 2023, with an adjusted EBITDA margin of 19.1%.
USPI Segment Growth
The USPI segment reported $439 million in adjusted EBITDA, representing a 19% growth over Q3 2023. Same-facility revenues increased by 8.7%.
Hospital Segment Progress
Hospital segment adjusted EBITDA was $539 million, indicating an 11% growth over Q3 2023. Same-store hospital admissions increased by 5.2%, with revenue per adjusted admission up 3.3%.
Increased 2024 Guidance
Tenet raised its full-year 2024 adjusted EBITDA guidance to a range of $3.9 billion to $4 billion, an increase of $50 million at the midpoint over prior guidance.
Portfolio Transformation
Completed the sale of Alabama hospitals, enhancing the return profile of the current hospital portfolio. Conifer has retained and, in many cases, expanded relationships with acquirers.
Deleveraging Success
Tenet reported a leverage ratio of around 3 on an EBITDA minus NCI basis, demonstrating significant deleveraging accomplishments.